Physician profile
Stephen K Roeske
NPI 1114378213
$6,554.11
in general payments reported to CMS, 2019-2025
16 companies · $1,646 in 2025
The $1,646 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $370 · 2021: $1,765 · 2022: $1,072 · 2023: $465 · 2024: $893 · 2025: $1,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,686 · Travel and Lodging: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,685.94 |
| Travel and Lodging | $317.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,463.92 | 2019-2025 | Infinity Adaptis, Flexband, Inbone |
| Treace Medical Concepts, INC. | $1,654.57 | 2021-2023 | |
| Organogenesis INC. | $483.71 | 2019-2022 | |
| Smith+Nephew, INC. | $480.56 | 2019-2025 | Stravix Pl, Stravix Mesh, Grafix Pl |
| Medline Industries LP | $154.98 | 2024 | |
| Abbott Laboratories | $68.34 | 2022-2023 | Proclaim |
| Melinta Therapeutics, LLC | $41.48 | 2019 | |
| In2bones USA, LLC | $33.88 | 2019 | |
| Encore Medical, LP | $32.71 | 2022 | |
| Misonix INC | $28.86 | 2019 | |
| Nalu Medical, INC. | $28.15 | 2022 | |
| Horizon Therapeutics Plc | $18.60 | 2023 | Krystexxa |
| Kerecis Limited | $18.21 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zimmer Biomet Holdings, INC. | $17.31 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.16 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $13.67 | 2023 | Surgx, Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Roeske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.